The already fragile trade relationship between India and the United States has come under fresh strain after the Trump administration imposed a 100 per cent tariff on branded and patented pharmaceutical products imported from India. The move, announced earlier this week, adds to an already steep tariff regime, with duties on some Indian goods reaching.
